This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.
Hereditary Aspects of Colorectal Cancer
Michael J. Hall, MD, MS
Fox Chase Cancer Center
Heather Hampel, MS, LGC
The Ohio State University
Learn about Lynch syndrome and other hereditary colorectal cancer syndromes, in addition to which patients are at risk, how to screen for these syndromes, and the relationship between biomarkers and targeted therapies for colorectal cancer. With 95% of Americans with Lynch syndrome unaware of their condition, it is vital that advanced practitioners in oncology be well-versed in the hereditary aspects of colorectal cancer to ensure patients are diagnosed effectively and receive the appropriate treatment.
These CME/CE/CPE accredited activities are jointly provided by